{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:14:50Z","timestamp":1790871290909,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T00:00:00Z","timestamp":1279756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Ovarian carcinoma (OvCa) is the most lethal gynecological malignancy among women and its poor prognosis is mainly due to metastasis. Chemokine receptor CCR9 is primarily expressed by a small subset of immune cells and its only natural ligand, CCL25, is largely expressed in the thymus, which involutes with age. Other than the thymus, CCL25 is expressed by the small bowel. Interactions between CCL25 and CCR9 have been implicated in leukocyte trafficking to the small bowel, a frequent metastatic site for OvCa cells. The current study shows OvCa tissue and cells significantly express CCR9, which interacts with CCL25 to support carcinoma cell migration and invasion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>RT-PCR and flow cytometry techniques were used to quantify the expression CCR9 by OvCa cells. OvCa tissue microarrays (TMA) was used to confirm CCR9 expression in clinical samples. The Aperio ScanScope scanning system was used to quantify immunohistochemical staining. Cell invasion and migration assays were performed using cell migration and matrigel invasion chambers. Matrix metalloproteinase (MMP) mRNAs were quantified by RT-PCR and active MMPs were quantified by ELISA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our results show significantly (<jats:italic>p<\/jats:italic>&lt; 0.001) higher expression of CCR9 by mucinous adenocarcinoma, papillary serous carcinoma, and endometriod ovarian carcinoma cases, than compared to non-neoplastic ovarian tissue. Furthermore, CCR9 expression was significantly elevated in OvCa cell lines (OVCAR-3 and CAOV-3) in comparison to normal adult ovarian epithelial cell mRNA. OvCa cells showed higher migratory and invasive potential towards chemotactic gradients of CCL25, which was inhibited by anti-CCR9 antibodies. Expression of collagenases (MMP-1, -8, and -13), gelatinases (MMP-2 and -9), and stromelysins (MMP-3, -10, and -11) by OvCa cells were modulated by CCL25 in a CCR9-dependent fashion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These results demonstrate both biological significance and clinical relevance of CCL25 and CCR9 interactions in OvCa cell metastasis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1477-7819-8-62","type":"journal-article","created":{"date-parts":[[2010,7,22]],"date-time":"2010-07-22T18:17:20Z","timestamp":1279822640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion"],"prefix":"10.1186","volume":"8","author":[{"given":"Erica L","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal M","family":"Johnson-Holiday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E","family":"Grizzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward E","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"James W","family":"Lillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,22]]},"reference":[{"key":"701_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1477-7827-1-68","volume":"1","author":"D Cvetkovic","year":"2003","unstructured":"Cvetkovic D: Early events in ovarian oncogenesis. Reprod Biol Endocrinol. 2003, 1: 68-10.1186\/1477-7827-1-68.","journal-title":"Reprod Biol Endocrinol"},{"key":"701_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1477-7827-1-70","volume":"1","author":"A Wong","year":"2003","unstructured":"Wong A, Auersperg N: Ovarian surface epithelium: family history and early events in ovarian cancer. Reprod Biol Endocrinol. 2003, 1: 70-10.1186\/1477-7827-1-70.","journal-title":"Reprod Biol Endocrinol"},{"key":"701_CR3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1200\/JCO.2001.19.2.368","volume":"19","author":"S Braun","year":"2001","unstructured":"Braun S, Schindlbeck C, Hepp F, Janni W, Kentenich C, Riethmuller G, Pantel K: Occult Tumor Cells in Bone Marrow of Patients With Locoregionally Restricted Ovarian Cancer Predict Early Distant Metastatic Relapse. J Clin Oncol. 2001, 19: 368-375.","journal-title":"J Clin Oncol"},{"key":"701_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.5483\/BMBRep.2003.36.1.128","volume":"36","author":"S Yoon","year":"2003","unstructured":"Yoon S, Park S, Yun C, Chung A: Roles of Matrix Metallo-proteinases in Tumor Metastasis and Angiogenesis. J Biochem Mol Biol. 2003, 36: 128-137.","journal-title":"J Biochem Mol Biol"},{"key":"701_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.critrevonc.2003.10.008","volume":"49","author":"P Myriam","year":"2004","unstructured":"Myriam P, B\u00e9atrice N-R, Christine G, Christine C, Philippe B: Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol. 2004, 49: 179-10.1016\/j.critrevonc.2003.10.008.","journal-title":"Crit Rev Oncol Hematol"},{"key":"701_CR6","first-page":"2885","volume":"25","author":"A Demeter","year":"2005","unstructured":"Demeter A, Sziller I, Csapo Z, Olah J, Keszler G, Jeney A, Papp Z, Staub M: Molecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer. Anticancer Res. 2005, 25: 2885-2889.","journal-title":"Anticancer Res"},{"key":"701_CR7","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1515\/BC.2003.137","volume":"384","author":"B Hantke","year":"2003","unstructured":"Hantke B, Harbeck N, Schmalfeldt B, Claes I, Hiller O, Luther M-O, Welk A, Kuhn W, Schmitt M, Tschesche H, Muehlenweg B: Clinical relevance of matrix metalloproteinase-13 determined with a new highly specific and sensitive ELISA in ascitic fluid of advanced ovarian carcinoma patients. Biol Chem. 2003, 384: 1247-1251. 10.1515\/BC.2003.137.","journal-title":"Biol Chem"},{"key":"701_CR8","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1016\/S0959-8049(03)00427-1","volume":"39","author":"L Manenti","year":"2003","unstructured":"Manenti L, Paganoni P, Floriani I, Landoni F, Torri V, Buda A, Taraboletti G, Labianca R, Belotti D, Giavazzi R: Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma. Eur J Cancer. 2003, 39: 1948-1956. 10.1016\/S0959-8049(03)00427-1.","journal-title":"Eur J Cancer"},{"key":"701_CR9","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/labinvest.3700181","volume":"84","author":"S Singh","year":"2004","unstructured":"Singh S, Singh UP, Grizzle WE, Lillard JW: CXCL12-CXCR4 interactions modulates prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest. 2004, 84: 1666-1676. 10.1038\/labinvest.3700181.","journal-title":"Lab Invest"},{"key":"701_CR10","doi-asserted-by":"publisher","first-page":"8743","DOI":"10.1158\/1078-0432.CCR-04-0266","volume":"10","author":"S Singh","year":"2004","unstructured":"Singh S, Singh UP, Stiles JK, Grizzle WE, Lillard JW: Expression and Functional Role of CCR9 in Prostate Cancer Cell Migration and Invasion. Clin Cancer Res. 2004, 10: 8743-8750. 10.1158\/1078-0432.CCR-04-0266.","journal-title":"Clin Cancer Res"},{"key":"701_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1387\/ijdb.041814hk","volume":"48","author":"H Kulbe","year":"2004","unstructured":"Kulbe H, Levinson NR, Balkwill F, Wilson JL: The chemokine network in cancer--much more than directing cell movement. Int J Dev Biol. 2004, 48: 489-496. 10.1387\/ijdb.041814hk.","journal-title":"Int J Dev Biol"},{"key":"701_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/86286","volume":"2","author":"RM Strieter","year":"2001","unstructured":"Strieter RM: Chemokines: Not just leukocyte chemoattractants in the promotion of cancer. Nat Immunol. 2001, 2: 285-10.1038\/86286.","journal-title":"Nat Immunol"},{"key":"701_CR13","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1046\/j.1365-3083.2003.01263.x","volume":"57","author":"J Dellacasagrande","year":"2003","unstructured":"Dellacasagrande J, Schreurs OJ, Hofgaard PO, Omholt H, Steinsvoll S, Schenck K, Bogen B, Dembic Z: Liver metastasis of cancer facilitated by chemokine receptor CCR6. Scand J Immunol. 2003, 57: 534-544. 10.1046\/j.1365-3083.2003.01263.x.","journal-title":"Scand J Immunol"},{"key":"701_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ijc.23083","volume":"122","author":"H Kajiyama","year":"2008","unstructured":"Kajiyama H, Shibata K, Terauchi M, Ino K, Nawa A, Kikkawa F: Involvement of SDF-1alpha\/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer. 2008, 122: 91-99. 10.1002\/ijc.23083.","journal-title":"Int J Cancer"},{"key":"701_CR15","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ijc.23083","volume":"122","author":"H Kajiyama","year":"2008","unstructured":"Kajiyama H, Shibata K, Terauchi M, Ino K, Nawa A, Kikkawa F: Involvement of SDF-1alpha\/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma. Int J Cancer. 2008, 122: 91-99. 10.1002\/ijc.23083.","journal-title":"Int J Cancer"},{"key":"701_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/01.cej.0000236259.88146.a4","volume":"16","author":"Y Yuecheng","year":"2007","unstructured":"Yuecheng Y, Xiaoyan X: Stromal-cell derived factor-1 regulates epithelial ovarian cancer cell invasion by activating matrix metalloproteinase-9 and matrix metalloproteinase-2. Eur J Cancer Prev. 2007, 16: 430-435. 10.1097\/01.cej.0000236259.88146.a4.","journal-title":"Eur J Cancer Prev"},{"key":"701_CR17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1101\/gad.14.2.163","volume":"14","author":"Q Yu","year":"2000","unstructured":"Yu Q, Stamenkovic I: Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000, 14: 163-176.","journal-title":"Genes Dev"},{"key":"701_CR18","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.4049\/jimmunol.165.9.5069","volume":"165","author":"KA Papadakis","year":"2000","unstructured":"Papadakis KA, Prehn J, Nelson V, Cheng L, Binder SW, Ponath PD, Andrew DP, Targan SR: The role of thymus-expressed chemokine and its receptor CCR9 on lymphocytes in the regional specialization of the mucosal immune system. J Immunol. 2000, 165: 5069-5076.","journal-title":"J Immunol"},{"key":"701_CR19","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.1182\/blood.V98.9.2626","volume":"98","author":"M-A Wurbel","year":"2001","unstructured":"Wurbel M-A, Malissen M, Guy-Grand D, Meffre E, Nussenzweig MC, Richelme M, Carrier A, Malissen B: Mice lacking the CCR9 CC-chemokine receptor show a mild impairment of early T- and B-cell development and a reduction in T-cell receptor gamma delta + gut intraepithelial lymphocytes. Blood. 2001, 98: 2626-2632. 10.1182\/blood.V98.9.2626.","journal-title":"Blood"},{"key":"701_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A M\u00fcller","year":"2001","unstructured":"M\u00fcller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Ver\u00e1stegui E, Zlotnik A: Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001, 410: 50-56. 10.1038\/35065016.","journal-title":"Nature"},{"key":"701_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1517\/14728220902762928","volume":"13","author":"C Koenecke","year":"2009","unstructured":"Koenecke C, Forster R: CCR9 and inflammatory bowel disease. Expert Opin Ther Targets. 2009, 13: 297-306. 10.1517\/14728220902762928.","journal-title":"Expert Opin Ther Targets"},{"key":"701_CR22","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1615\/CritRevImmunol.v23.i56.10","volume":"23","author":"D Kabelitz","year":"2003","unstructured":"Kabelitz D, Wesch D: Features and functions of gamma delta T lymphocytes: focus on chemokines and their receptors. Crit Rev Immunol. 2003, 23: 339-370. 10.1615\/CritRevImmunol.v23.i56.10.","journal-title":"Crit Rev Immunol"},{"key":"701_CR23","first-page":"53","volume":"47","author":"MD Morarescu","year":"2006","unstructured":"Morarescu MD, Simionescu C, Rosculescu I, Bala S, Cernea N, Patru E: Histopatological aspects of endometroid carcinoma in correlation to the state of tumoral progression in women patients during their premenopausal period. Rom J Morphol Embryol. 2006, 47: 53-58.","journal-title":"Rom J Morphol Embryol"},{"key":"701_CR24","doi-asserted-by":"publisher","first-page":"xiv","DOI":"10.1111\/j.0022-202X.2004.22346.x","volume":"122","author":"ST Hwang","year":"2004","unstructured":"Hwang ST: Chemokine receptors in melanoma: CCR9 has a potential role in metastasis to the small bowel. J Invest Dermatol. 2004, 122: xiv-xv. 10.1111\/j.0022-202X.2004.22346.x.","journal-title":"J Invest Dermatol"},{"key":"701_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.0022-202X.2004.22315.x","volume":"122","author":"A Letsch","year":"2004","unstructured":"Letsch A, Keilholz U, Schadendorf D, Assfalg G, Asemissen AM, Thiel E, Scheibenbogen C: Functional CCR9 expression is associated with small intestinal metastasis. J Invest Dermatol. 2004, 122: 685-690. 10.1111\/j.0022-202X.2004.22315.x.","journal-title":"J Invest Dermatol"},{"key":"701_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1600-0897.2005.00265.x","volume":"53","author":"C Zhou","year":"2005","unstructured":"Zhou C, Wu J, Borillo J, Torres L, McMahon J, Bao Y, Lou YH: Transient expression of CC chemokine TECK in the ovary during ovulation: its potential role in ovulation. Am J Reprod Immunol. 2005, 53: 238-248. 10.1111\/j.1600-0897.2005.00265.x.","journal-title":"Am J Reprod Immunol"},{"key":"701_CR27","first-page":"650","volume":"23","author":"QL Gao","year":"2004","unstructured":"Gao QL, Ma D, Meng L, Wang SX, Wang CY, Lu YP, Zhang AL, Li J: Association between Nm23-H1 gene expression and metastasis of ovarian carcinoma. Ai Zheng. 2004, 23: 650-654.","journal-title":"Ai Zheng"},{"key":"701_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF00132204","volume":"13","author":"AL Veatch","year":"1995","unstructured":"Veatch AL, Carson LF, Ramakrishnan S: Phenotypic variations and differential migration of NIH:OVCAR-3 ovarian carcinoma cells isolated from athymic mice. Clin Exp Metastasis. 1995, 13: 165-172. 10.1007\/BF00132204.","journal-title":"Clin Exp Metastasis"},{"key":"701_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/molehr\/3.1.27","volume":"3","author":"DL Hulboy","year":"1997","unstructured":"Hulboy DL, Rudolph LA, Matrisian LM: Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod. 1997, 3: 27-45. 10.1093\/molehr\/3.1.27.","journal-title":"Mol Hum Reprod"},{"key":"701_CR30","doi-asserted-by":"publisher","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","volume":"274","author":"H Nagase","year":"1999","unstructured":"Nagase H, Woessner JF: Matrix metalloproteinases. J Biol Chem. 1999, 274: 21491-21494. 10.1074\/jbc.274.31.21491.","journal-title":"J Biol Chem"},{"key":"701_CR31","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev.cb.09.110193.002545","volume":"9","author":"WG Stetler-Stevenson","year":"1993","unstructured":"Stetler-Stevenson WG, Aznavoorian S, Liotta LA: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol. 1993, 9: 541-573. 10.1146\/annurev.cb.09.110193.002545.","journal-title":"Annu Rev Cell Biol"},{"key":"701_CR32","first-page":"3450","volume":"7","author":"GC Durkan","year":"2001","unstructured":"Durkan GC, Nutt JE, Tajjayabun PH, Neal DE, Lunec J, Mellon JK: Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder. Clin Cancer Res. 2001, 7: 3450-3456.","journal-title":"Clin Cancer Res"},{"key":"701_CR33","first-page":"4823","volume":"6","author":"CE Brinckerhoff","year":"2000","unstructured":"Brinckerhoff CE, Rutter JL, Benbow U: Interstitial Collagenases as Markers of Tumor Progression. Clin Cancer Res. 2000, 6: 4823-4830.","journal-title":"Clin Cancer Res"},{"key":"701_CR34","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1016\/j.ejca.2003.08.011","volume":"39","author":"S Stadlmann","year":"2003","unstructured":"Stadlmann S, Pollheimer J, Moser PL, Raggi A, Amberger A, Margreiter R, Offner FA, Mikuz G, Dirnhofer S, Moch H: Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer. Eur J Cancer. 2003, 39: 2499-2505. 10.1016\/j.ejca.2003.08.011.","journal-title":"Eur J Cancer"},{"key":"701_CR35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0002-9440(10)65293-5","volume":"154","author":"N Johansson","year":"1999","unstructured":"Johansson N, Vaalamo M, Grenman S, Hietanen S, Klemi P, Saarialho-Kere U, Kahari V-M: Collagenase-3 (MMP-13) is Expressed by Tumor Cells in Invasive Vulvar Squamous Cell Carcinomas. Am J Pathol. 1999, 154: 469-480.","journal-title":"Am J Pathol"},{"key":"701_CR36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1699-0463.1999.tb01525.x","volume":"107","author":"M Balbin","year":"1999","unstructured":"Balbin M, Pendas AM, Uria JA: Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors. APMIS. 1999, 107: 45-53. 10.1111\/j.1699-0463.1999.tb01525.x.","journal-title":"APMIS"},{"key":"701_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/(SICI)1096-9098(199810)69:2<99::AID-JSO10>3.0.CO;2-M","volume":"69","author":"A Sehgal","year":"1998","unstructured":"Sehgal A, Keener C, Boynton AL, Warrick J, Murphy GP: CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol. 1998, 69: 99-104. 10.1002\/(SICI)1096-9098(199810)69:2<99::AID-JSO10>3.0.CO;2-M.","journal-title":"J Surg Oncol"},{"key":"701_CR38","first-page":"2396","volume":"7","author":"B Schmalfeldt","year":"2001","unstructured":"Schmalfeldt B, Prechtel D, Harting K, Spathe K, Rutke S, Konik E, Fridman R, Berger U, Schmitt M, Kuhn W, Lengyel E: Increased Expression of Matrix Metalloproteinases (MMP)-2, MMP-9, and the Urokinase-Type Plasminogen Activator Is Associated with Progression from Benign to Advanced Ovarian Cancer. Clin Cancer Res. 2001, 7: 2396-2404.","journal-title":"Clin Cancer Res"},{"key":"701_CR39","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ygyno.2005.07.009","volume":"99","author":"M Rauvala","year":"2005","unstructured":"Rauvala M, Puistola U, Turpeenniemi-Hujanen T: Gelatinases and their tissue inhibitors in ovarian tumors; TIMP-1 is a predictive as well as a prognostic factor. Gynecol Oncol. 2005, 99: 656-663. 10.1016\/j.ygyno.2005.07.009.","journal-title":"Gynecol Oncol"},{"key":"701_CR40","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1601-0825.2000.tb00130.x","volume":"6","author":"B Birkedal-Hansen","year":"2000","unstructured":"Birkedal-Hansen B, Pavelic ZP, Gluckman JL, Stambrook P, Li YQ, Stetler-Stevenson WG: MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues. Oral Dis. 2000, 6: 376-382. 10.1111\/j.1601-0825.2000.tb00130.x.","journal-title":"Oral Dis"},{"key":"701_CR41","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s004280000261","volume":"437","author":"J Mueller","year":"2000","unstructured":"Mueller J, Brebeck B, Schmalfeldt B, Kuhn W, Graeff H, Hofler H: Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential. Virchows Arch. 2000, 437: 618-624. 10.1007\/s004280000261.","journal-title":"Virchows Arch"},{"key":"701_CR42","first-page":"5379","volume":"43","author":"TC Hamilton","year":"1983","unstructured":"Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR, Ozols RF: Characterization of a Human Ovarian Carcinoma Cell Line (NIH:OVCAR-3) with Androgen and Estrogen Receptors. Cancer Res. 1983, 43: 5379-5389.","journal-title":"Cancer Res"},{"key":"701_CR43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ijc.2910550119","volume":"55","author":"JM Liebman","year":"1993","unstructured":"Liebman JM, Burbelo PD, Yamada Y, Fridman R, Kleinman HK: Altered expression of basement-membrane components and collagenases in ascitic xenografts of OVCAR-3 ovarian cancer cells. Int J Cancer. 1993, 55: 102-109. 10.1002\/ijc.2910550119.","journal-title":"Int J Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-8-62.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1477-7819-8-62\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-8-62.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T07:44:27Z","timestamp":1685691867000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-8-62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,22]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["701"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-8-62","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,22]]},"assertion":[{"value":"19 February 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"62"}}